Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Stockholders Equity of $3.77 million for fiscal year 2025.
CHAMPIONS ONCOLOGY, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $3.77M | +298.2% |
| 2024 | -$1.90M | -141.0% |
| 2023 | $4.64M | -49.0% |
| 2022 | $9.10M | +22.5% |
| 2021 | $7.43M | -8.1% |
| 2021 | $8.09M | +58.6% |
| 2020 | $5.10M | +138.6% |
| 2019 | $2.14M | +71133.3% |
| 2018 | $3.0K | -99.2% |
| 2017 | $400.0K | +68.1% |
| 2016 | $238.0K | -97.0% |
| 2015 | $8.06M | +152.1% |
| 2014 | $3.20M | +134.7% |
| 2013 | -$9.21M | -74.4% |
| 2012 | -$5.28M | -27878.9% |
| 2011 | $19.0K | -98.8% |
| 2010 | $1.58M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $4.28M | -21.7% | +2.7% |
| October 31, 2025 | $4.17M | +512.3% | +18.9% |
| July 31, 2025 | $3.51M | +1156.6% | -7.0% |
| April 30, 2025 | $3.77M | +298.2% | -31.0% |
| January 31, 2025 | $5.47M | +365.7% | +703.1% |
| October 31, 2024 | $681.0K | +632.3% | +305.1% |
| July 31, 2024 | -$332.0K | -117.4% | +82.6% |
| April 30, 2024 | -$1.90M | -141.0% | +7.5% |
- CHAMPIONS ONCOLOGY, INC. showed an increase of +298.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, CHAMPIONS ONCOLOGY, INC.’s stockholders equity has grown by 139.2% (from $1.58 million to $3.77 million).
- The most recent figure is from CHAMPIONS ONCOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: